Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT05498051
Eligibility Criteria:
Inclusion Criteria:
* Oral and written informed consent (IC)
* Aged 18 years and older
* Patients with pathologically confirmed and/or suspected cT1-3N0-2M0 colon carcinoma.
Exclusion Criteria:
* Distant metastasis
* Suspicion of cT4 disease based on pre-operative assessment
* Metastatic or T4 disease discovered during intraoperative staging
* Pregnancy, lactation or a planned pregnancy during the course of the study
* Previous colon surgery, excluding appendectomy.
* Contra-indication for laparoscopic/robotic surgery
* Inadequately controlled hypertension with or without current antihypertensive medication.
* Within 6 months prior to inclusion: myocardial infarction, TIA, CVA, pulmonary embolism, unstable angina pectoris, or uncontrolled chronic hepatic failure.
* Regarding Bevacizumab: Hypersensitivity to Chinese Hamster Ovary (CHO) cell products or other recombinant human or humanised antibodies. Or an allergy for it's components (Trehalose dehydrate, sodium phosphate, polysorbate 20, water for injections)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05498051
Study Brief:
Protocol Section:
NCT05498051